Routine Use of Gradient-Echo MRI to Screen for Cerebral Amyloid Angiopathy in Elderly Patients
D. A. Walker1,
D. F. Broderick1,
A. L. Kotsenas1 and
F. A. Rubino2
1 Department of Radiology, Mayo Clinic, 4500 San Pablo Rd., Jacksonville, FL
32224-1865. 2 Department of Neurology, Mayo Clinic, Jacksonville, FL 32224-1865.
Fig. 1A.71-year-old woman with biopsy-proven cerebral amyloid
angiopathy. Gradient-refocused echo images show multiple small (< 5 mm)
round foci of decreased signal intensity that are conspicuous.
Fig. 1B.71-year-old woman with biopsy-proven cerebral amyloid
angiopathy. T2-weighted fast spin-echo images show same small hypointensities
as in A to be barely discernible.
Fig. 1C.71-year-old woman with biopsy-proven cerebral amyloid
angiopathy. Diffusion-weighted images also show same hypointensities as in
A to be barely discernible, if at all.
Fig. 2.Bar graph shows percentage of total patients evaluated as
positive or negative for cerebral microbleeding (CMB) in lobarcortical
pattern typical of cerebral amyloid angiopathy.
Fig. 3.Bar graph shows percentage of patients positive for cerebral
microbleeding in which cerebral amyloid angiopathy (CAA) was clinically
unsuspected.
Fig. 4.Bar graph shows percentage of patients in both patient groups
(positive or negative for cerebral microbleeding [CMB]) who were taking
warfarin sodium (black bar) or aspirin (white bar).